NASDAQ · Biotechnology

PLYX (PLYX) Stock

$1.90 -2.99% NASDAQ: PLYX Healthcare

Valuation

MetricValue
Price$1.90
Market Cap$94.78M
P/E Ratio-18.00
P/B Ratio32.38
P/S Ratio0.00
EPS (TTM)$-0.19
52-Week High$48.91
52-Week Low$1.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-180.00%
ROA-180.00%
ROCE-200.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.00

Annual Financials (USD)

Metric202320242025
Revenue$0$0$0
Operating Profit$-4.0M$-4.0M$-8.0M
Net Profit$-4.0M$-30.0M$-9.0M
EPS$-0.02$-0.16$-0.19
Op Margin———

Balance Sheet (USD)

Metric202320242025
Total Assets$2.0M$5.0M$5.0M
Total Liabilities$1.0M$0$1.0M
Cash$0$5.0M$5.0M
Borrowings$0$0$0

Latest News

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial GlobeNewswire · May 28, 2026 Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards GlobeNewswire · May 14, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$0$-3.0M$-4.0M
Investing Cash Flow$0$0$0
Financing Cash Flow$0$0$0
Net Cash Flow$0$5.0M$1.0M
Free Cash Flow$0$-3.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.47%
Quick Ratio3.45
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held69.34%
Institutions Held4.55%
Institutions Float Held14.84%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,658,3882026-03-31
Geode Capital Management, LLC170,6732026-03-31
Millennium Management Llc127,5252026-03-31
Vanguard Fiduciary Trust Co104,5562026-03-31
State Street Corporation58,1042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About PLYX

PLYX is led by CEO Alex Yang, employs 11 people, headquartered in US, publicly traded since 2026.

PLYX stock trades at $1.90 with a market capitalization of $94.78M. The stock is valued at a price-to-earnings (P/E) ratio of -18.00, price-to-book of 32.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.90 and $48.91, and currently trades 96.1% below its 52-week high.

On profitability, PLYX generates a return on equity (ROE) of -180.00%, return on capital employed of -200.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides